Creates a surgical robotics company with a compelling product portfolio. Expected to accelerate commercialization timeline and revenue ramp.
(1888PressRelease) March 12, 2020 - Nano Medicevo (ISIN: JP3630033300), a privately-held medical company that offers products and services to advance the entire medical treatment process from diagnosis to post treatment care, is pleased to announce that is pioneering the use of robotics to improve minimally invasive surgery, also announced today that it has acquired the surgical robotics division of Precision Cut of a Taiwan health care company, in a cash and stock transaction with total consideration. Precision Cut has developed the Precision Cut® advanced robotic system for minimally invasive surgery.
"The combination of Surgical Proficiency™ and Precision Cut® will allow Nano Medicevo to address a larger market opportunity with compelling patient, surgeon and hospital value," said Seigo M. Iwasaki, President and CEO of Nano Medicevo. "We believe this combination accelerates our commercialization timeline and revenue ramp as we can immediately begin selling the Precision Cut in many markets globally."
"We believe joining with Nano Medicevo will make our vision to create the next wave of robotic surgery a reality." said Bunji Kyo, CEO of Precision Cut, who has been appointed to the Nano Medicevo Board of Directors. "Our decision to become a significant shareholder reflects our belief that the company has built a strong team and will execute on this compelling opportunity."
The combination with Precision Cut surgical robotics division supports and accelerates Nano Medicevo's fundamental strategies:
• Accelerate the migration of traditional laparoscopic procedures to robotically assisted laparoscopy: Both robotic surgical systems are designed to leverage the experience and motion of traditional laparoscopic surgery. Laparoscopic procedures represent over 10 times the number of existing robotic surgery procedures. New robotic systems that leverage laparoscopic experience and techniques should facilitate the continued growth of robotically enhanced laparoscopy.
• Address the trade-offs required of surgeons when using currently available robots.
• Eliminate cost barriers to adoption with compelling pricing models: Both robotic systems are designed to present a compelling economic value to hospitals. Whether through reduced capital acquisition cost or reduced per-procedure costs, each system will lower the economic barriers for hospitals to engage in robotic surgery. This should make robotic surgery a possibility for many more hospitals around the world.
About Nano Medicevo
Nano Medicevo is a privately-held medical company focused on developing advanced surgery systems and miniaturized robots for general surgery procedures. Nano Medicevo has set out to transform robot-assisted surgery, with proprietary technology that has the potential to far surpass today’s best solutions. Providing unprecedented access and maneuverability, the Nano Medicevo’s NanoPrecision™ Robotic Surgical System features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation for various access configurations. Nano Medicevo Surgery Systems’ mission is to innovate, support and simplify illness fighting solutions everywhere so we can realize our vision of living in a disease-free world.
Creates a surgical robotics company with a compelling product portfolio. Expected to accelerate commercialization timeline and revenue ramp. 
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam